QFR® as a predictive tool for post PCI physiology In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist on his/her research…
Read More
May 27, 2021
May 18, 2021
Medis Suite MR is our solution for the assessment of the different structures of the heart and the heart’s function in both scientific research and in clinical routine. It comes…
Read More
May 12, 2021
QFR® as a new tool for the assessment of non-culprit lesions in ACS In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a…
Read More
May 10, 2021
QFR® identified additional lesions at risk for future nontarget vessel–related events in STEMI through 5 years of follow up. Dr Sarah Bär et al from Univ of Bern, Switzerland carried…
Read More
May 4, 2021
QFR® is the innovative technology allowing for the assessment of functional significant coronary lesions, without the use of adenosine and the use of pressure wires. In addition detailed anatomical information…
Read More
May 3, 2021
In a recent prospective study in 421 patients, the fluoroscopy time (FT) was measured. With QFR® the FT was only 47% of that of FFR and 30% of iFR. QFR®…
Read More
